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Pulmonary and retroperitoneal benign metastasizing 
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Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Korea
Benign metastasizing leiomyoma (BML) is a rare disease, which usually occurs in women with a history of a prior hysterectomy or myomecto-
my for benign uterine leiomyoma, and has the potential to metastasize to distant sites, such as the lung, lymph nodes, muscular tissue, heart, 
or retroperitoneum. These lesions are slow-growing, asymptomatic, and usually found incidentally. The prognosis of BML is also excellent. How-
ever, there has been debate on the origin and the correct classification of BML, and there are no guidelines for the treatment of BML. We report 
here on a rare case of BML in both the retroperitoneal cavity and lung in a 48-year-old woman with a history of hysterectomy due to histologi-
cally benign uterine leiomyoma. The patient underwent retroperitoneal mass excision and bilateral salpingo-oophorectomy, and then wedge 
biopsy of two pulmonary nodules was performed additionally 9 days later. Until now, there has been no sign of recurrence and the patient re-
mains asymptomatic. To our knowledge, pulmonary BML is rare and the co-existence of the retroperitoneal metastases after previous hysterec-
tomy is even rarer.
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Introduction
Uterine leiomyoma is the most common gynecological tumor, and 
it usually occurs in the fourth and fifth decades of life. It usually grows 
during a women’s reproductive period and frequently regresses after 
menopause. However, uterine smooth-muscle tumors with unusual 
growth patterns, such as benign metastasizing leiomyoma (BML), in-
travenous leiomyomatosis and leiomyomatosis peritonealis dissemi-
nata, rarely exist. Of them, BML has been described as originating 
from the metastasis of the histologically benign uterine leiomyoma 
and is an uncommon lesion characterized by the presence of multi-
ple smooth-muscle nodules frequently located in the lung, lymph 
nodes, or abdomen [1, 2]. Depending on their location, different ter-
minologies, including intravenous leiomyomatosis (when found in 
vascular channels) and disseminated peritoneal leiomyomatosis 
(when found in the peritoneal cavity) have been used to describe 
leiomyomas found outside the confines of the uterus [1].
We describe a rare case of the retroperitoneal and pulmonary BML 
occurring simultaneously in a 48-year-old woman with a history of 
hysterectomy due to histologically benign uterine leiomyoma.
Case report
A 48-year-old woman, gravida 2, was referred to our outpatient 
clinic for the evaluation of an incidental pelvic mass and multiple 
lung nodules. She was asymptomatic and did not suffer from ab-
dominal pain, loss of weight, or any other respiratory symptoms like 
hemoptysis, purulent sputum or exertional dyspnea. Her past medi-
cal history was remarkable in that she had had a myomectomy 20 
years earlier and then underwent a total abdominal hysterectomy 8 
years later because of recurrent multiple uterine leiomyomas. In the 
initial physical and pelvic examination, a huge firm mass occupying 
the pelvic cavity was detected. On vaginal ultrasonography, a solid 
mass with myoma echotexture mass (14×15 cm in diameter) filling 
the pelvic cavity was identified and both ovaries were of normal ap-
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pearance. Chest radiography revealed that it was well-defined, with 
several nodules in both lung fields and the chest computed tomog-
raphy (CT) confirmed the aforementioned findings of uncertain ori-
gin (Figure 1). Pelvic CT and magnetic resonance image (MRI) showed 
a lobulating retroperitoneal mass measuring 148×100×154 mm at 
the right posterior aspect of the vaginal stump in continuity with the 
vaginal apex (Figure 2). Routine laboratory investigations and tumor 
markers including alpha-fetoprotein, CA 19-9 and CA-125, were re-
vealed to be within normal range. Fine needle aspiration of the lung 
nodule was performed, but the sample obtained from the fine nee-
dle aspiration was inadequate for tissue diagnosis. Therefore, the ret-
roperitoneal mass excision and bilateral salpingo-oophorectomy were 
performed, followed by wedge biopsy of two pulmonary nodules 9 
days later. An intraoperative frozen section from the retroperitoneal 
tumor suggested a leiomyoma.
There was no necrosis or degeneration on the gross or microscopic 
examination (Figure 3). The microscopic findings of the lung and ret-
roperitoneal masses showed nodular proliferation of spindle cells 
(Figure 4). The mitotic index was low (less than 1 per 10 high-power 
fields) and the proliferation index defined by Ki-67 immunostaining 
(1:200; DAKO, Glostrup, Denmark) was very low (less than 1%). The 
spindle cells showed diffuse immunopositivity for smooth muscle 
actin (1:200; DAKO, Carpinteria, CA, USA), but neither nuclear atypia 
nor mitotic activity were identified. The immunohistochemical stain-
ing for estrogen and progesterone receptors were positive in the pul-
monary nodules and the retroperitoneal mass. On the basis of these 
findings, we diagnosed the pulmonary nodules and the retroperito-
neal lesion as BML. Until now, there has been no sign of recurrence 
and the patient remains asymptomatic.
A B
Figure 1. A chest radiograph (A) and computed tomography scan (B) revealed multiple peripheral nodules in the both lungs.
12.97 mm
Figure 2. Magnetic resonance image showed a lobulating retroperi-
toneal mass (*) in the pelvic cavity.
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  Clin Exp Reprod Med 2011;38(3):174-177
176
Discussion
Benign metastasizing leiomyoma is rare disease, which usually oc-
curs in women with a history of a prior hysterectomy or myomecto-
my for benign uterine leiomyoma, and has the potential to metasta-
size to distant sites, such as the lung, skin, bone, mediastinum, lymph 
nodes, muscular tissue, heart, and retroperitoneum [3]. These lesions 
are slow-growing, asymptomatic, and usually found incidentally. In 
one study, the mean duration between the hysterectomy and the 
appearance of the lung lesions was 15 years (range, 3 months to 20 
years) [4]. To our knowledge, our case is the first report of metastatic 
lesion in the retroperitoneal cavity and lung occurring simultaneously 
in Korea, although 5 other cases of metastases to the lung alone after 
hysterectomy have been reported in Korea [5-9]. The term “BML” was 
used based on the presupposition that these tumors originate from 
the metastasis of the histologically benign-appearing uterine leio-
myoma that cannot, based upon morphological criteria alone, be 
recognized as its malignant counterpart, leiomyosarcoma [1]. Actual-
ly, it may represent a heterogenous group of smooth muscle tumors, 
ranging from leiomyoma to low grade leiomyosarcoma [10]. Howev-
er, there has been debate on the origin and the correct classification 
of BML, and several hypotheses for the pathogenesis of BML have 
been proposed. Some investigators have assumed that BML is a be-
nign uterine lesion that is spread via a hematogenous route to the 
lungs or other organs, in that a majority of patients have undergone 
myomectomy or hysterectomy suggesting surgically induced hema-
togenous spread [11]. Supporting this theory is the hormone depen-
dence of both the uterine and the pulmonary lesion. However, the 
lesion in the lung might take up to 20 years to grow large enough to 
be detectable. Others groups have argued that uterine lesions and 
Figure 3. Gross findings of the retroperitoneal mass (A) and pulmonary nodule (B).
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Figure 4. Microscopic findings of the retroperitoneal mass (A) and pulmonary nodule (B). The lesions contain spindle-shaped smooth muscle 
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the associated BML are clonal proliferations, as it is generally recog-
nized as one mechanism by which endometriosis can be found at 
distant sites [11, 12]. Patton et al. [11] reported that pulmonary and 
uterine leiomyomas showed identical patterns of androgen receptor 
allelic inactivation, indicating that they were monoclonal in origin. 
Also, they showed that the telomere length measured by fluorescence 
in situ hybridization in both tumors was long or very long indicating 
that significant telomere shortening is not a crucial step for develop-
ing metastases in these tumors. Therefore, this may be a better theo-
ry for describing the truly benign process of BML. Other authors have 
claimed that all BMLs represent misdiagnosed low grade leiomyosar-
comas. Paley and Fornasier [13] reviewed 8 cases of leiomyosarcoma 
metastasizing to the bone; the primary lesion of the uterus was first 
diagnosed as leiomyoma but after review appeared to be an under-
diagnosed low grade leiomyosarcoma. Although there are limitations 
in histopathologic testing, they suggested that a definite diagnosis 
of BML should only be made after careful review of the numerous 
samples of the primary uterine leiomyoma to exclude small foci of 
missing sarcoma [14].
Currently there are no guidelines for the treatment of BML due to 
the limited number of reported cases. Treatment methods include 
surgical resection of the BML lesion and careful observation. Also, re-
moval of estrogen stimulation by bilateral oophorectomy or hormon-
al therapy using a gonadotropin-releasing hormone agonist, proges-
terone, selective estrogen receptor modulator, or aromatase inhibitor 
has been suggested as the best option for unresectable metastatic 
lesions [3]. The rationale for the use of hormonal therapy is based on 
the presence of estrogen and progesterone receptors in both prima-
ry tumors as well as in the metastatic nodules [10]. However, because 
BML could recur after menopause and despite previous oophorecto-
my, such patients should have prolonged surveillance after surgical 
removal or hormonal suppression [1]. In addition, tumor resection 
and biopsy is essential to establish a diagnosis of BML because ma-
lignant tumors may exhibit a similar appearance at imaging or clini-
cal examination [2].
To our knowledge, our case is the first report of BML with a huge 
mass in the retroperitoneal cavity and multiple pulmonary nodules 
occurring simultaneously in Korea. Although pulmonary BML is rare 
and the co-existence of the retroperitoneal metastases after previous 
hysterectomy is even rarer, we suggest that such patients should have 
prolonged surveillance and careful follow-up.
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